Share

April 08, 2014; 82 (10 Supplement) April 29, 2014

GNbAC1, a Humanized Monoclonal Antibody Against The Multiple Sclerosis Associated Retrovirus Envelope Protein, Is Well Tolerated In Patients With Multiple Sclerosis. (P2.217)

Tobias Derfuss, Francois Curtin, Alois Lang, Herve Perron, Ludwig Kappos, Patrice LaLive
First published April 9, 2014,
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 82 no. 10 Supplement P2.217
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 9, 2014.
Copyright & Usage: 
Copyright © 2014 by AAN Enterprises, Inc.

Author Disclosures

    1. Tobias Derfuss4,
    2. Francois Curtin2,
    3. Alois Lang3,
    4. Herve Perron3,
    5. Ludwig Kappos5 and
    6. Patrice LaLive1
  1. Tobias Derfuss4,
  2. Francois Curtin2,
  3. Alois Lang3,
  4. Herve Perron3,
  5. Ludwig Kappos5 and
  6. Patrice LaLive1
  1. 1Geneva Switzerland
  2. 2GeNeuro SA Geneva Switzerland
  3. 3GeNeuro SA Plan les Ouates Switzerland
  4. 4Neurologische Uniklinik Basel Basel Switzerland
  5. 5Neurology and Department of Biomedicine, University Hospital Basel Switzerland

Article usage

Article usage: April 2014 to August 2023

AbstractFullPdfSource
Apr 201414000Highwire
May 20145000Highwire
Jun 20143000Highwire
Jul 20144100Highwire
Aug 20143700Highwire
Sep 20142800Highwire
Oct 20141200Highwire
Nov 20143500Highwire
Dec 201413100Highwire
Jan 20155400Highwire
Feb 20151400Highwire
Mar 20152100Highwire
Apr 20151300Highwire
May 20152200Highwire
Jun 20152000Highwire
Jul 20151300Highwire
Aug 20151800Highwire
Sep 20151300Highwire
Oct 20152200Highwire
Nov 20151000Highwire
Dec 20153400Highwire
Jan 20163600Highwire
Feb 20161700Highwire
Mar 20161800Highwire
Apr 20163100Highwire
May 20163000Highwire
Jun 20163200Highwire
Jul 2016900Highwire
Aug 20161300Highwire
Sep 20161200Highwire
Oct 201614600Highwire
Nov 20161300Highwire
Dec 2016700Highwire
Jan 2017900Highwire
Feb 2017800Highwire
Mar 20171400Highwire
Apr 2017700Highwire
May 20177200Highwire
Jun 20176300Highwire
Jul 2017500Highwire
Aug 20171100Highwire
Sep 2017800Highwire
Oct 2017300Highwire
Nov 2017900Highwire
Dec 2017600Highwire
Jan 2018800Highwire
Feb 2018900Highwire
Mar 20181200Highwire
Apr 2018800Highwire
May 20181200Highwire
Jun 20181700Highwire
Jul 2018400Highwire
Aug 2018100Highwire
Sep 2018100Highwire
Oct 20181200Highwire
Nov 20181100Highwire
Dec 2018900Highwire
Jan 20192100Highwire
Feb 2019900Highwire
Mar 2019400Highwire
Apr 2019500Highwire
May 2019500Highwire
Jun 2019500Highwire
Jul 2019800Highwire
Aug 2019400Highwire
Sep 2019300Highwire
Oct 2019700Highwire
Nov 2019800Highwire
Dec 2019200Highwire
Jan 2020500Highwire
Mar 2020100Highwire
Apr 2020200Highwire
Jul 2020100Highwire
Aug 2020400Highwire
Sep 2020500Highwire
Oct 2020200Highwire
Nov 2020600Highwire
Dec 2020800Highwire
Jan 2021200Highwire
Feb 2021100Highwire
Mar 2021600Highwire
Apr 2021900Highwire
May 20211500Highwire
Jun 2021300Highwire
Jul 2021700Highwire
Aug 20211100Highwire
Sep 2021200Highwire
Oct 2021300Highwire
Nov 2021200Highwire
Dec 2021100Highwire
Jan 2022100Highwire
Feb 2022700Highwire
Mar 2022500Highwire
Apr 2022100Highwire
May 2022300Highwire
Jun 2022400Highwire
Aug 2022100Highwire
Sep 2022100Highwire
Oct 2022200Highwire
Nov 2022500Highwire
Dec 2022200Highwire
Feb 2023200Highwire
Mar 2023200Highwire
Apr 2023500Highwire
May 2023200Highwire
Jun 2023400Highwire
Aug 2023100Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me